Business
Anke-Peggy Holtorf, PhD, MBA, Diana Brixner, RPh, PhD, Brandon Bellows, PharmD, Abdulkadir Keskinaslan, MD, MBA, MPH, Joseph Dye, RPh, PhD, Gary Oderda, PharmD, MPH
Health Economics and Outcomes Research Data Key in Coverage Decisions of New Medications
Disruptive Innovation, Uncertain Value, and Economic Modeling in Oncology
The Lessons from Delaware's Employee Benefits Program
Sally Amanuel, MSc, MA, MBA, Paola Antonini, MD, PhD, Victoria Coutinho, MSc, PhD, Thomas Goss, PharmD, Zhihong Lai, PhD, Sotiris Rompas, Phd, Michael F. Murphy, MD, PhD
Michael C. Runken, PharmD, Joshua M. Noone, PhD, Christopher M. Blanchette, PhD, MBA, Emily Zacherle, MS, Reuben Howden, PhD
Shared Decision-Making and Payer Preferences: IVIG or SCIG Route of Administration?
Value-Based Drug Benefit: Implications for Manufacturers
Bettina M. Beech, DrPH, MPH, Tristan Cordier, MPH, Laura E. Happe, PharmD, MPH, Laura Trunk, MD, Gilbert S. Haugh, MS, Richard Kwong, MPH, Vipin Gopal, PhD, Roy A. Beveridge, MD
Patients’ Choice for Site of Care Motivated by More Than Cost Alone
Shelby Corman, PharmD, MS, BCPS, Xin Gao, PhD, Sizhu Liu, MS, Reema Mody, PhD,MBA, Haridarshan Patel, PharmD, Yin Wan, MS, BSPharm
Opioid-Induced Constipation Associated with Considerable Economic Burden